Quick Answer
Elanco Animal Health Inc reported Cash And Cash Equivalents At Carrying Value of $545.00 million for the year ending 2025.
- Elanco Animal Health Inc showed an increase of +16.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Elanco Animal Health Inc's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $343.60 million | Q1 2018: $263.40 million | Q2 2018: $321.00 million | Q3 2018: $300.00 million | Q1 2019: $272.10 million | Q2 2019: $385.10 million | Q3 2019: $309.20 million | Q1 2020: $1.21 billion | Q2 2020: $1.39 billion | Q3 2020: $660.00 million | Q1 2021: $515.00 million | Q2 2021: $580.00 million | Q3 2021: $453.00 million | Q1 2022: $342.00 million | Q2 2022: $507.00 million | Q3 2022: $460.00 million | Q1 2023: $318.00 million | Q2 2023: $367.00 million | Q3 2023: $369.00 million | Q1 2024: $345.00 million | Q2 2024: $416.00 million | Q3 2024: $490.00 million | Q1 2025: $487.00 million | Q2 2025: $539.00 million | Q3 2025: $505.00 million.
- Over the full 9 years of available data (2017 to 2025), Elanco Animal Health Inc's Cash And Cash Equivalents At Carrying Value has grown by 68.5%.
- Historical annual values: Fiscal year 2025: $545.00 million | Fiscal year 2024: $468.00 million | Fiscal year 2023: $352.00 million | Fiscal year 2022: $345.00 million | Fiscal year 2021: $638.00 million | Fiscal year 2020: $495.00 million | Fiscal year 2019: $334.00 million | Fiscal year 2018: $474.80 million | Fiscal year 2017: $323.40 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: